X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (45) 45
index medicus (43) 43
male (35) 35
middle aged (27) 27
oncology (24) 24
aged (23) 23
prostate cancer (21) 21
female (19) 19
adult (18) 18
article (18) 18
metastasis (18) 18
radiology, nuclear medicine & medical imaging (16) 16
treatment outcome (16) 16
cancer (14) 14
magnetic resonance imaging (14) 14
tumors (14) 14
antineoplastic agents - therapeutic use (12) 12
retrospective studies (12) 12
abridged index medicus (10) 10
urology & nephrology (10) 10
aged, 80 and over (9) 9
bone metastases (9) 9
care and treatment (9) 9
chemotherapy (9) 9
diffusion magnetic resonance imaging - methods (9) 9
metastases (9) 9
patients (9) 9
prostatic neoplasms - pathology (9) 9
bone neoplasms - secondary (8) 8
clinical trials (8) 8
magnetic resonance imaging - methods (8) 8
prostate-cancer (8) 8
reproducibility of results (8) 8
therapy (8) 8
urology (8) 8
whole body imaging - methods (8) 8
medical research (7) 7
mutation (7) 7
neoplasm metastasis (7) 7
prostatic neoplasms, castration-resistant - pathology (7) 7
sensitivity and specificity (7) 7
survival (7) 7
analysis (6) 6
diagnosis (6) 6
diffusion (6) 6
patient outcomes (6) 6
prostate (6) 6
prostatic neoplasms, castration-resistant - drug therapy (6) 6
trial (6) 6
usage (6) 6
young adult (6) 6
biomarker (5) 5
biomarkers (5) 5
bone neoplasms - diagnostic imaging (5) 5
cell biology (5) 5
computed tomography (5) 5
diagnostic radiology (5) 5
diffusion-weighted imaging (5) 5
medicine & public health (5) 5
methods (5) 5
neoplasm staging (5) 5
prognosis (5) 5
radiology (5) 5
solid tumors (5) 5
abiraterone (4) 4
adolescent (4) 4
antineoplastic agents - administration & dosage (4) 4
clinical-trials (4) 4
diffusion magnetic resonance imaging (4) 4
diffusion mri (4) 4
disease (4) 4
dna (4) 4
dna repair (4) 4
genetic aspects (4) 4
health aspects (4) 4
heterogeneity (4) 4
image enhancement - methods (4) 4
increased survival (4) 4
mutations (4) 4
nuclear magnetic resonance--nmr (4) 4
piperazines - therapeutic use (4) 4
progression (4) 4
prospective studies (4) 4
prostate-specific antigen - blood (4) 4
prostatic neoplasms - diagnostic imaging (4) 4
prostatic neoplasms - genetics (4) 4
tomography, x-ray computed (4) 4
tumor burden (4) 4
validation (4) 4
whole body imaging (4) 4
whole-body mri (4) 4
abiraterone acetate (3) 3
acquired-resistance (3) 3
animals (3) 3
antigens (3) 3
antineoplastic agents - adverse effects (3) 3
biomarkers, tumor (3) 3
biopsy (3) 3
bone diseases (3) 3
bone neoplasms - diagnosis (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Imaging, ISSN 1470-7330, 2015, Volume 15, Issue Suppl 1, p. O35
Journal Article
Cancer Imaging (BioMed), ISSN 1470-7330, 10/2014, Volume 14, Issue 9022, pp. O38 - O38
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2015, Volume 373, Issue 18, pp. 1697 - 1708
Journal Article
Science, ISSN 0036-8075, 02/2018, Volume 359, Issue 6378, pp. 920 - 926
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2011, Volume 29, Issue 10, pp. 1271 - 1279
Purpose The hepatocyte growth factor/c-MET axis is implicated in tumor cell proliferation, survival, and angiogenesis. ARQ 197 is an oral, selective,... 
GROWTH FACTOR/SCATTER FACTOR | LUNG-CANCER | ANGIOGENESIS | ONCOLOGY | HEALTHY-SUBJECTS | TYROSINE KINASE | ENDOTHELIAL-CELLS | PROSTATE-CANCER | CARCINOMAS | PERIPHERAL-BLOOD | TUMOR-CELLS | Proto-Oncogene Proteins c-met - metabolism | Phosphorylation | Neoplastic Cells, Circulating - pathology | Apoptosis - drug effects | Humans | Middle Aged | Aryl Hydrocarbon Hydroxylases - genetics | Pyrrolidinones - pharmacokinetics | England | Receptors, Growth Factor - antagonists & inhibitors | Male | Protein Kinase Inhibitors - adverse effects | Quinolines - pharmacokinetics | Young Adult | Angiogenesis Inhibitors - therapeutic use | Adult | Female | Neovascularization, Pathologic - prevention & control | Angiogenesis Inhibitors - adverse effects | Focal Adhesion Kinase 1 - metabolism | In Situ Nick-End Labeling | Protein Kinase Inhibitors - pharmacokinetics | Neoplastic Cells, Circulating - drug effects | Pyrrolidinones - adverse effects | Proto-Oncogene Proteins c-met - antagonists & inhibitors | Pyrrolidinones - therapeutic use | Neoplasms - enzymology | Neoplasms - blood supply | Treatment Outcome | Angiogenesis Inhibitors - pharmacokinetics | Aryl Hydrocarbon Hydroxylases - metabolism | Neoplasms - drug therapy | Magnetic Resonance Imaging | Maximum Tolerated Dose | Signal Transduction - drug effects | Biopsy | Cytochrome P-450 CYP2C19 | Protein Kinase Inhibitors - therapeutic use | Adolescent | Aged | Polymorphism, Single Nucleotide | Quinolines - therapeutic use | Endothelial Cells - pathology | Neoplasms - pathology | Quinolines - adverse effects | Endothelial Cells - drug effects | Receptors, Growth Factor - metabolism | Index Medicus
Journal Article
Journal Article
European Radiology, ISSN 0938-7994, 4/2018, Volume 28, Issue 4, pp. 1687 - 1691
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 06/2005, Volume 171, Issue 11, pp. 1292 - 1297
Journal Article
Magnetic Resonance Imaging Clinics of North America, ISSN 1064-9689, 11/2018, Volume 26, Issue 4, pp. 527 - 542
Journal Article
Journal Article
BMC Cancer, ISSN 1471-2407, 06/2017, Volume 17, Issue 1, pp. 456 - 8
Journal Article
Journal Article